INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

233 studies · page 9 of 10

2022 / Randomized, double-blind clinical trial

Turmeric combined with piperine reduced MDA and ferritin levels more effectively than turmeric alone in hemodialysis patients.

Hemodialysis patients aged 20-75 were randomized to receive 12 weeks of turmeric alone (3 g/day) or turmeric with piperine (3 g turmeric + 2 mg piperine/day). The turmeric/piperine group showed significantly greater reductions in MDA [-0.08(-0.14/0.01) nmol/mL vs -0.003(-0.10/0.26) nmol/mL, p=0.003] and ferritin [-193.80 ± 157.29 mg/mL vs 51.99 ± 293.25 mg/mL, p=0.018] compared to turmeric alone. Additionally, GPx activity decreased in the turmeric group (p=0.029), while no changes were observed for CAT, GR, or hs-CRP.

Freitas E Silva-Santana NC, Rodrigues HCN, Pereira Martins TF, et al. Free Radic Biol Med, 2022. PMID 36370961

2020 / Randomized controlled trial

Soursop juice lowered blood pressure and serum uric acid in a prehypertensive population.

In a randomized controlled trial, 143 subjects with essential prehypertension and high-normal serum uric acid (SUA) levels were assigned to receive 2 × 100 g soursop fruit juice daily or no treatment for 3 months. The soursop group showed significantly lower mean systolic blood pressure after adjustment across examinations, and the control group was more likely to have prehypertension, hypertension, and high-normal or high SUA levels at 6 and 12 weeks. In an analysis using 2017 ACC/AHA guidelines, both systolic and diastolic blood pressure were significantly lower in the treatment group than the control group after 12 weeks.

Alatas H, Sja'bani M, Mustofa M, et al. J Hum Hypertens, 2020. PMID 31462727

2020 / Parallel-group, double-blind, randomized controlled trial

Vitamin K2 supplementation for one year did not improve vascular stiffness or other vascular health measures in patients with CKD stage 3b or 4.

A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.

Witham MD, Lees JS, White M, et al. J Am Soc Nephrol, 2020. PMID 32817311

2018 / Phase 1 placebo-controlled study and observational analyses

In a phase 1 study, oral nicotinamide boosted circulating NAD+ metabolites, was well tolerated, and was associated with less acute kidney injury.

In critically ill patients, an elevated urinary quinolinate/tryptophan ratio predicted acute kidney injury (AKI) and other adverse outcomes. A phase 1 placebo-controlled study of oral nicotinamide (NAM) demonstrated a dose-related increase in circulating NAD+ metabolites. Oral NAM was well tolerated and was associated with less AKI. The study also examined murine models of AKI.

Poyan Mehr A, Tran MT, Ralto KM, et al. Nat Med, 2018. PMID 30127395

2017 / Randomized controlled trial

Hibiscus sabdariffa extract increased urine volume and creatinine clearance compared to placebo in Nigerians with mild to moderate hypertension.

A total of 78 newly diagnosed but untreated hypertensive subjects were randomized into three equal groups receiving Hibiscus sabdariffa (HS), lisinopril, or placebo once daily for 4 weeks. HS and lisinopril both significantly increased urine volume compared to placebo (P < 0.001), with HS increasing it significantly more than lisinopril (P < 0.001). Additionally, HS significantly increased creatinine clearance compared to placebo (P < 0.001), whereas lisinopril did not.

Nwachukwu DC, Aneke EI, Nwachukwu NZ, et al. J Physiol Sci, 2017. PMID 27221151

2017 / Randomized trial

Adhering to a vegan diet for 7 consecutive days raised 24-h urine pH, whereas adherence for 2-3 days per week did not, though both reduced dietary PRAL scores.

Healthy adult omnivores were randomly assigned to follow a vegan diet for 7 consecutive days (VEG7), 3 evenly spaced days (VEG3), or 2 evenly spaced days (VEG2) over one week. Outcome measures did not differ between VEG2 and VEG3, so they were collapsed for analysis. After the 1-week intervention, 24-h urine pH increased in the 7-day adherence group (+0.52 ± 0.69) but was unchanged in the 2-3 day adherence group (-0.02 ± 0.56, p = 0.048). However, dietary PRAL scores decreased significantly in both groups during the trial.

Cosgrove K, Johnston CS Plant Foods Hum Nutr, 2017. PMID 28677099

2014 / Randomized controlled trial

Whole soy attenuated estimated glomerular filtration rate decline in prehypertensive postmenopausal women.

A randomized controlled trial assigned 270 equol-producing postmenopausal Chinese women with prehypertension to daily soy flour (40 g), low-fat milk powder with daidzein (63 mg), or milk powder placebo for 6 months. Most kidney markers did not differ significantly between groups. However, whole soy intake led to a smaller decrease in Cockcroft-Gault estimated glomerular filtration rate over 6 months (p = 0.044) and percent change (p = 0.031) compared to placebo.

Liu ZM, Ho SC, Chen YM, et al. Clin Biochem, 2014. PMID 24877660

2013 / Comparative crossover trial

Dark chocolate intake reduced renal medullary R2*, indicating increased tissue oxygenation, in healthy volunteers.

Ten healthy volunteers underwent BOLD-MRI before and 2 hours after consuming 1 g/kg dark chocolate (70% cocoa), with eight repeating the protocol with 1 g/kg white chocolate after at least 1 week. Mean medullary R2* was significantly lower after dark chocolate compared to baseline (28.2 ± 1.3 s-1 vs. 29.6 ± 1.3 s-1, p = 0.04), indicating increased oxygenation, while white chocolate caused no cortical or medullary changes. The change in medullary R2* correlated with circulating (epi)catechines (r = 0.74, p = 0.037) and was independent of plasma renin activity.

Pruijm M, Hofmann L, Charollais-Thoenig J, et al. Clin Nephrol, 2013. PMID 23557792

2013 / Sequential dietary intervention trial

Short-term high-salt intake expanded CD14++CD16+ monocytes and elevated monocyte-platelet aggregates in healthy adults, reversible by a low-salt diet.

Twenty healthy volunteers followed a 3-day usual diet, a 7-day high-salt diet (>=15 g NaCl/day), and a 7-day low-salt diet (<=5 g NaCl/day). Switching to a high-salt diet led to CD14++ monocyte activation, rapid expansion of the CD14++CD16+ subset and monocyte-platelet aggregates (MPAs), and a reciprocal decrease in CD14++CD16- and CD14+CD16++ subsets. High-salt intake was also associated with progressive hypoxia in the renal medulla and increased urinary MCP-1 excretion; these changes were completely reversed by a low-salt diet, while blood pressure remained unchanged.

Zhou X, Zhang L, Ji WJ, et al. PLoS One, 2013. PMID 23593194

2013 / Randomized controlled open-label trial protocol

A randomized trial protocol describes testing whether oral sodium bicarbonate supplementation slows kidney function decline in chronic kidney disease.

This study protocol outlines the SoBic-study, a single-center, randomized, controlled, open-label trial in Vienna. A planned 200 patients with chronic kidney disease stages 3 or 4 and chronic metabolic acidosis (serum HCO3- <21 mmol/L) will be randomized 1:1 to either high-dose oral sodium bicarbonate (target serum HCO3- 24±1 mmol/L) or rescue therapy (target 20±1 mmol/L) for two years. The primary outcome is change in renal function assessed by eGFR after two years.

Gaggl M, Cejka D, Plischke M, et al. Trials, 2013. PMID 23826760

2012 / Randomized controlled trial

Turmeric supplementation decreased proteinuria, hematuria, and systolic blood pressure in lupus nephritis.

A randomized trial assigned 24 patients with relapsing or refractory lupus nephritis to take three daily capsules of either starch placebo or 500 mg turmeric (22.1 mg curcumin each) for 3 months. In the turmeric group, proteinuria fell from 954.2 ± 836.6 at baseline to 260.9 ± 106.2 at 3 months, alongside reductions in hematuria and systolic blood pressure. No changes occurred in the control group, and no adverse effects were observed.

Khajehdehi P, Zanjaninejad B, Aflaki E, et al. J Ren Nutr, 2012. PMID 21742514

2012 / Clinical trial

Fruits and vegetables or sodium bicarbonate reduced kidney injury markers in stage 2 nephropathy.

Patients with hypertensive nephropathy and stage 1 or 2 estimated GFR received sodium bicarbonate, alkali-inducing produce, or no intervention for 30 days. No changes occurred in the stage 1 group. In stage 2 patients, both treatments reduced urinary excretion of albumin, transforming growth factor beta, and N-acetyl beta-D-glucosaminidase to an equivalent extent compared to controls.

Goraya N, Simoni J, Jo C, et al. Kidney Int, 2012. PMID 21881553

2012 / Randomized double-blind crossover trial and open-label extension

Curcumin dose may affect light-chain response and bone turnover in MGUS and SMM.

In a randomized, double-blind crossover study with 36 patients, participants received a 4g dose of curcumin or placebo for 3 months before crossing over, followed by an optional 8g open-label extension. Curcumin treatment decreased the free light-chain ratio and reduced the difference between clonal and nonclonal light chains. Urine DPYD, representing bone resorption, decreased with curcumin but rose with placebo, while serum creatinine tended to drop.

Golombick T, Diamond TH, Manoharan A, et al. Am J Hematol, 2012. PMID 22473809

2012 / Crossover dietary intervention study

An alkaline diet increased urine pH and uric acid clearance compared to an acidic diet in healthy female students.

Healthy female students consumed an acidic diet (protein-rich, fewer vegetables/fruits) and an alkaline diet (lower protein, vegetable- and fruit-rich) in consecutive 5-day tests. Urine pH reached a steady state 3 days after switching diets, and uric acid retained a linear relationship with excreted urine pH. Serum uric acid was higher and urinary uric acid was lower with the acidic diet compared to the alkaline diet, reflecting a reduction in uric acid clearance on the acidic diet.

Kanbara A, Miura Y, Hyogo H, et al. Nutr J, 2012. PMID 22676161

2011 / Intervention trial with ex vivo bacterial testing

Urine collected after oral cranberry juice cocktail consumption demonstrated reduced adhesion forces for clinical uropathogenic Escherichia coli strains.

A volunteer consumed a single 16 oz dose of either water or cranberry juice cocktail (CJC), and urine samples were collected at 0, 2, 4, 6, and 8 hours. The urine was tested ex vivo against six clinical uropathogenic E. coli strains and a control strain using atomic force microscopy. Within 2 hours of CJC consumption, clinical strains treated with the urine showed lower adhesion forces compared to baseline urine, with forces continuing to decrease over the 8-hour period. Urine collected after water consumption showed no change in adhesion forces.

Tao Y, Pinzón-Arango PA, Howell AB, et al. J Med Food, 2011. PMID 21480803

2011 / Crossover metabolic trial

Neutralizing dietary acid load did not prevent protein-induced increases in urinary calcium

In a short-term crossover metabolic study, 11 healthy volunteers consumed a control diet or a high-protein diet supplemented with potassium citrate or potassium chloride across four phases. Potassium citrate fully neutralized the dietary acid load and increased urinary citrate. Urinary calcium increased during both high-protein phases compared with control but was not significantly different between the high-protein plus potassium chloride and high-protein plus potassium citrate phases (182 ± 85 vs. 170 ± 85 mg/d; P = 0.28). The authors concluded this suggests, at least in the short term, mechanisms other than acid load account for high-protein diet-induced hypercalciuria.

Maalouf NM, Moe OW, Adams-Huet B, et al. J Clin Endocrinol Metab, 2011. PMID 21976719

2010 / Randomized crossover trial

Milk consumption acutely reduced serum urate concentrations in healthy men.

In a randomized controlled crossover trial of 16 healthy men, consuming intact skim milk products decreased serum urate concentrations by approximately 10% over three hours (p < 0.0001). In contrast, a soy control drink increased serum urate by roughly 10%. All test drinks increased fractional excretion of uric acid, with late-season milk producing a larger increase than ultrafiltrated milk (p = 0.02).

NANO counterpoint →

Dalbeth N, Wong S, Gamble GD, et al. Ann Rheum Dis, 2010. PMID 20472590

2008 / Longitudinal randomized clinical trial

A 4-year soy protein diet improved lipid levels, fasting glucose, CRP, and kidney biomarkers in type 2 diabetic patients with nephropathy.

Forty-one type 2 diabetic patients with nephropathy were randomized to consume a diet containing either 35% animal protein, 35% textured soy protein, and 30% vegetable protein (n=20) or 70% animal protein and 30% vegetable protein (n=21) for 4 years. Compared to controls, soy protein significantly reduced fasting plasma glucose (-18 +/- 3 vs. 11 +/- 2 mg/dl; P = 0.03), total cholesterol (-23 +/- 5 vs. 10 +/- 3 mg/dl; P = 0.01), LDL cholesterol (-20 +/- 5 vs. 6 +/- 2 mg/dl; P = 0.01), and triglycerides (-24 +/- 6 vs. -5 +/- 2 mg/dl; P = 0.01). Serum CRP significantly decreased (1.31 +/- 0.6 vs. 0.33 +/- 0.1 mg/l; P = 0.02), alongside significant improvements in proteinuria (-0.15 +/- 0.03 vs. 0.02 +/- 0.01 g/day; P = 0.001) and urinary creatinine (-1.5 +/- 0.9 vs. 0.6 +/- 0.3 mg/dl; P = 0.01).

Azadbakht L, Atabak S, Esmaillzadeh A Diabetes Care, 2008. PMID 18184902

2006 / Randomized clinical trial

A low-fat vegan diet led to greater improvements in glycemic control and cardiovascular risk factors than an ADA diet in people with type 2 diabetes.

Ninety-nine individuals with type 2 diabetes were randomly assigned to a low-fat vegan diet (n = 49) or an ADA guidelines diet (n = 50) for 22 weeks. Excluding participants who changed medications, HbA1c fell 1.23 points in the vegan group compared with 0.38 points in the ADA group (P = 0.01). Body weight decreased 6.5 kg in the vegan group compared with 3.1 kg in the ADA group (P < 0.001). Among those not changing lipid-lowering medications, LDL cholesterol fell 21.2% in the vegan group and 10.7% in the ADA group (P = 0.02), and urinary albumin reductions were also greater in the vegan group (15.9 mg/24 h vs. 10.9 mg/24 h, P = 0.013).

Barnard ND, Cohen J, Jenkins DJ, et al. Diabetes Care, 2006. PMID 16873779

2004 / Randomized crossover trial

Isolated soy protein reduced albumin excretion and improved lipids in diabetic nephropathy.

Fourteen men with type 2 diabetes and nephropathy received 0.5 g/(kg*d) of protein as isolated soy protein or casein for 8 weeks each in a crossover study. Soy protein intake significantly decreased urinary albumin excretion by 9.5% (P < 0.0001), lowered total-to-HDL (-0.45) and LDL-to-HDL (-0.20) ratios, and raised HDL cholesterol by 4.3% (P = 0.0040). Albumin excretion correlated negatively with plasma isoflavone levels.

Teixeira SR, Tappenden KA, Carson L, et al. J Nutr, 2004. PMID 15284369

2004 / Intervention study

Adding low-oxalate fruits and vegetables to hypocitraturic stone formers improved urinary parameters and reduced calcium oxalate relative saturation.

Researchers studied a 2-week fruit and vegetable elimination in 12 normal adults, and low-oxalate fruit and vegetable supplementation in 26 hypocitraturic calcium stone formers. In normal subjects, elimination decreased urinary potassium (-62%), magnesium (-26%), citrate (-44%), and oxalate (-31%), while increasing calcium (+49%), ammonium (+12%), and relative saturation for calcium oxalate and calcium phosphate. In stone formers, supplementation increased urinary volume (+64%), pH (5.84 to 6.19), potassium (+68%), magnesium (+23%), and citrate (+68%), and decreased calcium oxalate relative saturation (10.17 to 4.96) and uric acid relative saturation (2.78 to 1.12).

Meschi T, Maggiore U, Fiaccadori E, et al. Kidney Int, 2004. PMID 15569332

2002 / Randomized controlled trial

Normal calcium with low animal protein and salt reduced recurrent kidney stones.

A five-year randomized trial compared two diets in 120 men with hypercalciuria and recurrent calcium oxalate stones. Participants assigned to normal calcium with restricted animal protein and salt experienced fewer recurrences than those on a low-calcium diet (12 versus 23 relapses; relative risk 0.49; 95% CI, 0.24 to 0.98; P=0.04). Urinary calcium decreased similarly in both groups, but urinary oxalate output decreased on the normal-calcium diet while increasing on the low-calcium diet.

Borghi L, Schianchi T, Meschi T, et al. N Engl J Med, 2002. PMID 11784873

2002 / Randomized controlled trial

A low-protein diet reduced the risk of ESRD or death in patients with type 1 diabetic nephropathy over four years.

An 82-patient randomized controlled trial evaluated the effects of a low-protein diet (prescribed 0.6 g/kg/day) compared with a usual-protein diet over four years in type 1 diabetic patients with progressive diabetic nephropathy. Actual intake was 0.89 g/kg/day in the low-protein group versus 1.02 g/kg/day in the usual-protein group (P = 0.005). Mean declines in GFR were 3.8 mL/min/year in the low-protein group and 3.9 mL/min/year in the usual-protein group. ESRD or death occurred in 10% of patients on the low-protein diet compared with 27% on the usual-protein diet (P = 0.042; adjusted relative risk 0.23, 95% CI 0.07 to 0.72).

Hansen HP, Tauber-Lassen E, Jensen BR, et al. Kidney Int, 2002. PMID 12081581

2001 / Controlled feeding trial

Dietary oxalate contributed up to 52.6% of urinary oxalate excretion depending on intake levels and dietary calcium content.

Adults consumed formula diets (0 and 180 mg oxalate/2500 kcal) and controlled solid-food diets containing 10, 50, and 250 mg of oxalate/2500 kcal. Urinary oxalate excretion increased as dietary oxalate intake increased, with dietary oxalate contributing a mean of 24.4 +/- 15.5% on the 10 mg diet to 41.5 +/- 9.1% on the 250 mg diet. Reducing calcium content from 1002 mg to 391 mg in the 250 mg oxalate diet increased urinary oxalate excretion by a mean of 28.2 +/- 4.8% and increased the mean dietary contribution to 52.6 +/- 8.6%.

Holmes RP, Goodman HO, Assimos DG, et al. Kidney Int, 2001. PMID 11135080